Why former Mayor Peterson is stepping down from drugmaker Eli Lilly
Getting elected mayor requires fine-tuned political instincts. Sometimes, those instincts say it’s time to leave a high-level job at the biggest company in town.
Health Care & Life Sciences
Articles
Chinese firm working with Lilly gets positive results on cancer drug
Hutchison China MediTech Ltd., the biotechnology company that has a partnership with Eli Lilly and Co., on Friday reported positive late-stage results for its drug to treat colorectal cancer.
OneAmerica bets big on long-term-care market
Fast-growing business lines are hard to come by in the insurance industry. Locally based OneAmerica Financial Partners Inc. has one on its hands, and it’s beefing up efforts to capitalize.
Dealing with my cancer: Surgery, a tough recovery, and the magic words
Just when I thought getting through chemo was a tough challenge, I faced another—six days in the hospital to remove and replace my cancerous bladder. I hope the lessons I learned will make me a better journalist.
Drug companies willing to spend big in pursuit of Alzheimer’s cure
Alzheimer’s disease is rewriting the rules of drug discovery, with companies like Eli Lilly and others abandoning caution to keep pursuing an elusive hypothesis because the potential payoff is so great.
Former Mayor Peterson leaving Lilly after seven years
Eli Lilly and Co. said Bart Peterson, who served two terms as Indianapolis mayor, was stepping down as senior vice president "to pursue personal business interests" and expand his community volunteer commitments.
Republicans in Indiana warn of potential health repeal fallout
Republican legislative leaders in Indiana are warning that repealing the Affordable Care Act could unravel a program for poor residents that Vice President Mike Pence implemented as governor.
MDwise to exit Hoosier Care Connect program, cut 80 workers
MDwise said it could not reach an agreement with the Indiana Family and Social Services Administration’s Office of Medicaid Policy and Planning over payment rates for the Hoosier Care Connect program.
Trump tells Anthem, other health insurers to expect ‘something special’
The meeting between the president and U.S. health insurers on Monday was a chance for the industry to weigh in on promised changes to the Affordable Care Act that are beginning to come into focus.
High-tech compression garment maker lands FDA clearance
Fishers-based Recovery Force LLC took a big step this month toward its goal of bringing to market a wrap that’s designed to improve blood flow and enhance recovery for people battling serious health issues.
Anthem’s loveless marriage heads toward predictable end
Doubters about the $48 billion Anthem-Cigna merger have been in abundance from the start—both on antitrust grounds and on concerns over cultural fit.
State lawmakers send abortion bill goes back to committee
Indiana House Republicans are taking the unusual step of reassigning an abortion bill to the same panel that narrowly approved it last week.
As pricing criticism mounts, Lilly, other drugmakers roll out pay for performance
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Trump health pick from Indiana says Medicaid needs major overhaul
Indiana health care consulting executive Seema Verma on Thursday testified before the Senate Finance Committee on her nomination to lead the Centers for Medicare and Medicaid Services, or CMS.
Judge blocks Cigna from scuttling $48 billion deal with Anthem
Indianapolis-based Anthem Inc. on Wednesday won a court ruling blocking Cigna Corp. from terminating a proposed merger between the health insurers until a judge could weigh arguments over the faltering deal at an April 10 hearing.
Merck stops Alzheimer’s study after ‘no chance’ of benefit
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
Anthem sues to block Cigna from terminating $48B merger
In the lawsuit, Anthem blasted Cigna, accusing it of repeated efforts to sabotage their proposed merger.
Cigna seeks to terminate merger with Anthem, sues insurer for $13B
Indianapolis-based Anthem responded almost immediately Tuesday by saying Cigna does not have the right to cancel the deal.
Aetna gives up on $34B Humana deal, will pay $1B breakup fee
The Humana-Aetna deal was one of two mergers that would have reshaped the U.S. health insurance landscape. Both were rejected by federal judges as anticompetitive. Anthem hasn't given up on its deal—a $48 billion pact to acquire Cigna—and is pressing ahead with an appeal.
Indy-founded drug firm lands nearly $23M to fight rare disease
Two local men who have been working on a potential blockbuster treatment for a rare and debilitating disease are hopeful that a major injection of venture capital will provide the boost needed to move the drug to market—even if it means sweeping changes for their company.